Alasdair Marshall

ORCID: 0000-0002-9789-8042 · 4 papers in corpus
observational 2025
O-081 Serum metabolic profiling in endometriosis reveals a strong metabolic signature for peritoneal endometriosis
·doi:10.1093/humrep/deaf097.081

Abstract Study question What are the metabolome differences between the serum of patients with endometriosis and control subjects? What metabolic traits are characteristic of peritoneal and/or ovarian endometriosis? Summary answer Endometri…

other 2023
Comparing gene expression in deep infiltrating endometriosis with adenomyosis uteri: evidence for dysregulation of oncogene pathways
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-023-01083-9

BACKGROUND: The pathogenesis of deep infiltrating endometriosis (DIE) is poorly understood. It is considered a benign disease but has histologic features of malignancy, such as local invasion or gene mutations. Moreover, it is not clear whe…

lab-animal 2023
P-325 Evidence for dysregulation of oncogene pathways at the gene expression level in the epithelium of deep infiltrating endometriosis compared to adenomyosis
·doi:10.1093/humrep/dead093.683

Abstract Study question How does the gene expression profile of epithelium cells differ between deep infiltrating endometriosis (DIE) and adenomyosis (FA)? Summary answer The gene expression of epithelial cells from DIE reveals a significan…

2020
Expression von Fibronektin und Progranulin in eutopem Endometrium – potenzielle stadienabhängige Biomarker für die Endometriose
·doi:10.1055/s-0040-1717678

Zielsetzung 10-15 % aller Frauen im reproduktiven Alter sind von Endometriose betroffen. Dennoch sind die molekularen Mechanismen sowie die Pathogenese nicht vollständig geklärt. Das Ziel der Studie war, die unterschiedlichen Stadien der Er…